Steven C Huber

Title: The Innovations of Steven C Huber

Introduction

Steven C Huber is an accomplished inventor based in Savoy, IL (US). He holds a patent that showcases his contributions to the field of synthetic peptides and their applications in cancer therapeutics. His work is significant in the ongoing fight against neoplastic growth and related diseases.

Latest Patents

Huber's notable patent is titled "Synthetic peptides that cause F-actin bundling and block actin depolymerization." This patent describes synthetic peptides derived from sucrose synthase, which exhibit homology to actin and actin-related proteins. These peptides share a common motif that is useful for causing actin bundling and preventing actin depolymerization. The peptides can be beneficial for treating subjects suffering from diseases characterized by neoplastic growth, making them valuable for anti-cancer therapeutics. They can be delivered to subjects either solely or in conjunction with other known cancer treatments. Additionally, these peptides can stabilize microfilaments in living cells and inhibit cell growth.

Career Highlights

Throughout his career, Steven C Huber has worked with prestigious institutions such as the University of California and North Carolina State University. His experience in these organizations has contributed to his expertise in the field of synthetic peptides and their applications.

Collaborations

Huber has collaborated with notable colleagues, including Heike Sederoff and Carolyn A Larabell. These collaborations have further enriched his research and development efforts in the field.

Conclusion

Steven C Huber's innovative work in synthetic peptides represents a significant advancement in cancer therapeutics. His contributions are paving the way for new treatment options and enhancing our understanding of cellular processes.